BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 19820473)

  • 1. Determination of an environmental background level of 90Sr in urine for the Hanford bioassay program.
    Antonio CL; Rivard JW
    Health Phys; 2009 Nov; 97(5 Suppl):S180-2. PubMed ID: 19820473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comprehensive dose reconstruction methodology for former rocketdyne/atomics international radiation workers.
    Boice JD; Leggett RW; Ellis ED; Wallace PW; Mumma M; Cohen SS; Brill AB; Chadda B; Boecker BB; Yoder RC; Eckerman KF
    Health Phys; 2006 May; 90(5):409-30. PubMed ID: 16607174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of monitoring for internal exposure by urine bioassay in a biomedical research facility.
    Shoji M; Kondo T; Honoki H; Nakajima T; Muraguchi A; Saito M
    Radiat Prot Dosimetry; 2007; 127(1-4):456-60. PubMed ID: 17956934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Excreta Sampling as an Alternative to In Vivo Measurements at the Hanford Site.
    Carbaugh EH; Antonio CL; Lynch TP
    Health Phys; 2015 Aug; 109(2 Suppl 2):S141-7. PubMed ID: 26102322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of occupational exposure to uranium by indirect methods needs information on natural background variations.
    Muikku M; Heikkinen T; Puhakainen M; Rahola T; Salonen L
    Radiat Prot Dosimetry; 2007; 125(1-4):492-5. PubMed ID: 17309870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A rapid bioassay method for the determination of 90Sr in human urine sample.
    Sadi BB; Li C; Jodayree S; Lai EP; Kochermin V; Kramer GH
    Radiat Prot Dosimetry; 2010 Jun; 140(1):41-8. PubMed ID: 20167796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbon-14 bioassay for decommissioning of Hanford reactors.
    Carbaugh EH; Watson DJ
    Health Phys; 2012 May; 102(5 Suppl 2):S38-42. PubMed ID: 22469998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exposure of workers in a mineral processing industry in Brazil.
    Julião LM; Melo DR; Sousa WO; Santos MS; Fernandes PC; Godoy ML
    Radiat Prot Dosimetry; 2007; 125(1-4):513-5. PubMed ID: 17369613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Field deployable technique for 90Sr emergency bioassay.
    Li C; Sadi BB; Moodie G; Daka JN; Lai EP; Kramer GH
    Radiat Prot Dosimetry; 2009 Sep; 136(2):82-6. PubMed ID: 19692422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MDA improvement technique for lung counter measurements of uranium workers.
    Pelled O; German U; Pollak G; Tshuva A
    Radiat Prot Dosimetry; 2007; 125(1-4):496-9. PubMed ID: 17355982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of site profiles for dose reconstruction used in worker compensation claims.
    Kenoyer JL; Scalsky ED; Taulbee TD
    Health Phys; 2008 Jul; 95(1):47-54. PubMed ID: 18545029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Automated radioanalytical system for the determination of 90Sr in environmental water samples by 90Y Cherenkov radiation counting.
    O'Hara MJ; Burge SR; Grate JW
    Anal Chem; 2009 Feb; 81(3):1228-37. PubMed ID: 19138126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plutonium-related work and cause-specific mortality at the United States Department of Energy Hanford Site.
    Wing S; Richardson D; Wolf S; Mihlan G
    Am J Ind Med; 2004 Feb; 45(2):153-64. PubMed ID: 14748046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testing prediction capabilities of an 131I terrestrial transport model by using measurements collected at the Hanford nuclear facility.
    Apostoaei AI
    Health Phys; 2005 May; 88(5):439-58. PubMed ID: 15824593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uncertainty on faecal analysis on dose assessment.
    Julião LM; Melo DR; Sousa Wde O; Santos MS; Fernandes PC
    Radiat Prot Dosimetry; 2007; 127(1-4):421-4. PubMed ID: 18083997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of internal exposure of nuclear medicine staff through in vivo and in vitro bioassay techniques.
    Lucena EA; Rebelo AM; Araújo F; Sousa WO; Dantas AL; Dantas BM; Corbo R
    Radiat Prot Dosimetry; 2007; 127(1-4):465-8. PubMed ID: 17681960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One perspective on stakeholder involvement at Hanford.
    Martin T
    Health Phys; 2011 Nov; 101(5):536-8. PubMed ID: 21979534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. (32)P measurment of urine samples and internal dose assessment for radiation workers in life science laboratories.
    Yoon S; Pak MJ; Park S; Yoo J; Ha WH; Jang HK; Kim JK
    J Radiol Prot; 2014 Dec; 34(4):775-85. PubMed ID: 25325199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the uncertainty in internal dose estimate resulting from biological stochastic variability of excretion.
    Molokanov A; Blanchardon E
    Radiat Prot Dosimetry; 2007; 125(1-4):561-4. PubMed ID: 17848381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selectivity of 90Sr urine bioassay technique over 241Am, 238/239PU, 210PO, 137CS and 60CO.
    Sadi BB; Li C; Bahraini N; Lai EP; Kramer GH
    Radiat Prot Dosimetry; 2010 Sep; 141(2):205-9. PubMed ID: 20494955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.